Management of the Ageing Macula

Total Page:16

File Type:pdf, Size:1020Kb

Management of the Ageing Macula Eye (1987) 1,311-317 Management of the Ageing Macula E. L. CHUANG Miami, Florida Summary Age-related Macular Degeneration (AMD) is responsible for the majority of registered blindness in the elderly. Laser photocoagulation can be offered as a treatment of proven value to only a proportion of patients with neovascular AMD. Clinically, our expectations must be tempered by the high incidence of recurrent subretinal vessels, the anatomic limitations of treatable lesions and the large number of ageing eyes for which there is no place for laser. In addition to improve­ ments in education, referral habits and the application of laser therapy which may have an impact upon visual loss due to AMD, there are promising directions to be explored in alternative modes of treatment and prevention. It is well recognised that the leading cause of laser treatment, completed and in progress, blindness in the elderly is AMD. 1,2 This and and also cover limitations and failures of alternative designations such as senile macu­ therapy. Those manifestations of macular lar degeneration (SMD) are used by many ageing for which no treatment is currently authors to refer to all forms of macular ageing, appropriate will also be considered. Finally, whereas only those changes associated with mention will be made of less conventional loss of function are included under the desig­ therapeutic approaches under study and on nation AMD by others. The former definition the ultimate management, that is, possible is used here for drusen, retinal pigment epi­ prevention. thelial detachment, geographic atrophy and subretinal (choroidal) neovascularisation, State of The Art-Laser Treatment manifestations of ageing which do not occur It is appropriate to begin discussion of laser sequentially but rather exist in an interrelated treatment by reviewing briefly the effects of manner. photocoagulation in the target and neighbour­ Only a small proportion of patients with ing tissues. 4 These are based upon the con­ age-related changes suffer significant visual version of light energy to heat, the effects of loss. 2 Though it is one of the least common which are determined by irradiance, absorp­ manifestations of the ageing macula, subreti­ tion and tissue pathlength. Factors such as nal neovascularisation (SRNV) or disciform power, duration and spot size comprise irra­ degeneration is responsible for the vast diance, while heat absorption depends upon majority of these blind eyes. 3 the wavelength employed relative to pigments A significant proportion of these eyes pass present in the tissues and is affected by heat through a stage in which laser therapy can conduction as well as by light absorption and improve the visual prognosis. This review will scatter due to the lens. In the target tissues, concentrate upon neovascular complications the main heat-absorbing substances are of AMD, outlining the relevant studies of melanin, xanthophyll and haemoglobin, each Correspondence to: E. L. Chuang, Bascom Palmer Eye Institute, PO Box 016880, Miami, Florida 33101. From Retinal Diagnostic Department, Moorfields Eye Hospital, London, 312 E. L. CHUANG of which has a characteristic location lengths which must also be taken into account (pathlength) and relative absorption of dif­ in considering the effects of laser. ferent wavelengths. The clinically available lasers include Argon Blue-green and Green Present Clinical Management of AMD only, Krypton Red and Yellow, and most Photocoagulation is the only effective recently, the tuneable Dye Laser with which a modality presently available for the treatment wavelength may be chosen to best suit the of any of the sight-threatening complications of AMD, and is correctly applied only to neo­ individual setting.5 vascular lesions. Our currently accepted Melanin has a broad spectrum of absorp­ approach is based upon the results of three tion, such that its relative concentration in the recent randomised clinical trials which have retinal pigment epithelium (RPE) and shown significantly improved outcome with choroid is the primary determinant of energy Argon Blue-Green laser treatment for extra­ absorption. Spread of heat to neovascular foveal membranes in elderly populations.7 -9 complexes adjacent to the RPE and originat­ These studies varied in specific criteria used ing from the choroid is the principal means by for patient selection, treatment or follow-up, which closure of SRNV occurs. Melanin con­ but many features were common to all three. centration varies considerably with race and Eligible membranes causing symptoms were age: as the concentration of melanin treated with heavy and confluent burns decreases with age, higher power levels are extending beyond the angiographic limits of needed in order to create the desired photo­ the lesion. Visual results were better in eyes coagulative effects. Melanin absorbs longer treated compared to those observed in all wavelengths less than shorter ones. Therefore three studies. In the Macular Photocoagula­ with Red, more energy penetrates the RPE to tion Study (MPS), visual loss of six or more reach the choroid, a partial explanation for lines of acuity was present in 60 per cent of the deeper burns characteristic of Krypton untreated eyes vs 25 per cent of treated eyes Red versus Argon Blue-Green. 18 months after treatment.7 Stable or Haemoglobin absorbs Blue, Green and improved vision was twice as likely in treated Yellow well, but longer wavelengths poorly. eyes at six months. Similarly, in the British Therefore, retinal vascular and secondary and French studies, all analyses favoured inner retinal damage can be minimised by the treatment over observation.8,9 use of Red, as has been demonstrated histo­ Unfortunately, obtaining and maintaining logically.6 Furthermore, if there is a thin layer the benefits of treatment goes far beyond the of blood associated with a neovascular mem­ technical application of laser. Persistent or brane, relatively better penetration is recurrent SRNV following laser is an all too afforded by Red wavelengths, delivering frequent event. All three randomised studies more energy to the deeper target tissues. as well as other retrospective analyses which Xanthophyll absorbs Blue most, Green have included Krypton Red-treated eyes have minimally and Yellow or Red least. Like identified open vessels in close to 60 per cent melanin, its concentration is partially deter­ of eyes after intended obliterative photo­ mined by race. Furthermore, as melanin con­ coagulation.10--13 The vast majority of these centration decreases with age, the use of arise from the site of the original neo­ increasing power levels in order to create an vascularisation and its treatment, with only 8 adequate burn potentially leads to more sig­ per cent of 'recurrent' membranes in treated nificant absorption by xanthophyll. The pres­ MPS eyes located independently from treat­ ence of xanthophyll in the central macula, ment scars. Virtually all the recurrences arise primarily in the outer plexiform layer means from the foveal treatment edge, underlining that damage to the neurosensory retina can be the well-recognised tendency of neovascular minimised in this location by the use of longer membranes to grow toward the foveola and wavelengths. With ageing, the lens contains perhaps modified laser absorption in this increasing amounts of xanthophyll, leading to location as well as reluctance to apply Blue­ greater absorption and scatter of short wave- Green laser close to xanthophyll pigment. MANAGEMENT OF THE AGEING MACULA 313 The majority appear relatively early: with nised that the biologic behaviour of NVMs almost five year follow-up in the MPS, over 70 includes an initial period of greatest activity per cent of recorded recurrences were identi­ and growth. 18 Experience has identified an fied within the first year. 10 It is of significance interval of weeks from the onset of symptoms that analysis to date has not identified specific beyond which laser therapy results in a poorer features other than distance from the foveal visual outcome. 19 After treatment, patients avascular zone, which might be useful predic­ should be clearly and repeatedly informed of tors of eyes at higher risk for recurrence in the means and need to monitor central vision Argon treated eyes. The long-term visual out­ and of the importance of seeking immediate come is worsened because of the high number attention should symptoms arise. They and of recurrences, but still remains better than no referring eye care specialists must also have treatment at all since laser can be reapplied in ready access to appropriate evaluation. These eyes with recurrent SRNV which continue to measures should enhance our ability to meet treatment criteria. 14 approach the highest possible success rate The nature of recurrences reflects not only afforded by photocoagulation. features of the biologic nature of SRNV but In the best of circumstances, there will also less than optimal aspects of our presently always be individuals in whom the location of accepted treatment approach. If we can better an active NVM will begin or become sub­ understand and manage this common sequel foveal, so that there can be no hope for to laser treatment in neovascular AMD, the normal central vision. In such instances, laser visual prognosis in macular ageing will may still improve final visual function. It has undoubtedly improve. Though the use of been proposed that the size of the ultimate Argon Blue-Green is the only modality pres­ scotoma can be limited by
Recommended publications
  • Formation of Lipofuscin-Like Autofluorescent Granules in the Retinal Pigment Epithelium Requires Lysosome Dysfunction
    Retinal Cell Biology Formation of Lipofuscin-Like Autofluorescent Granules in the Retinal Pigment Epithelium Requires Lysosome Dysfunction Cristina Escrevente,1 Ana S. Falcão,1 Michael J. Hall,2 Mafalda Lopes-da-Silva,1 Pedro Antas,1 Miguel M. Mesquita,1 Inês S. Ferreira,1 M. Helena Cardoso,1 Daniela Oliveira,1 Ana C. Fradinho,1 Thomas Ciossek,3 Paul Nicklin,3 Clare E. Futter,2 Sandra Tenreiro,1 and Miguel C. Seabra1,2 1iNOVA4Health, CEDOC – Chronic Diseases Research Center, NOVA Medical School, Universidade Nova de Lisboa, Lisboa, Portugal 2UCL Institute of Ophthalmology, London, United Kingdom 3Research Beyond Borders, Boehringer Ingelheim, Biberach, Germany Correspondence: Miguel C. Seabra, PURPOSE. We aim to characterize the pathways required for autofluorescent granule (AFG) CEDOC - NOVA Medical School, formation by RPE cells using cultured monolayers. Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal; METHODS. We fed RPE monolayers in culture with a single pulse of photoreceptor outer [email protected]. segments (POS). After 24 hours the cells started accumulating AFGs that were compa- rable to lipofuscin in vivo. Using this model, we used a variety of light and electron Received: January 24, 2021 microscopical techniques, flow cytometry and Western blot to analyze the formation of Accepted: June 29, 2021 Published: July 27, 2021 AFGs. We also generated a mutant RPE line lacking cathepsin D by gene editing. Citation: Escrevente C, Falcão AS, RESULTS. AFGs seem to derive from incompletely digested POS-containing phagosomes Hall MJ, et al. Formation of and after 3 days are surrounded by a single membrane positive for lysosome markers. We lipofuscin-like autofluorescent show by various methods that lysosome-phagosome fusion is required for AFG formation, granules in the retinal pigment and that impairment of lysosomal pH or catalytic activity, particularly cathepsin D activity, epithelium requires lysosome enhances AF accumulation.
    [Show full text]
  • Mini-Review on Lipofuscin and Aging: Focusing on the Molecular Interface, the Biological Recycling Mechanism, Oxidative Stress, and the Gut-Brain Axis Functionality
    medicina Review Mini-Review on Lipofuscin and Aging: Focusing on The Molecular Interface, The Biological Recycling Mechanism, Oxidative Stress, and The Gut-Brain Axis Functionality Ovidiu-Dumitru Ilie 1,* , Alin Ciobica 1,2,*, Sorin Riga 2, Nitasha Dhunna 3, Jack McKenna 4, Ioannis Mavroudis 5,6, Bogdan Doroftei 7 , Adela-Magdalena Ciobanu 8 and Dan Riga 2 1 Department of Biology, Faculty of Biology, “Alexandru Ioan Cuza” University, Carol I Avenue, no 20A, 700505 Iasi, Romania 2 Academy of Romanian Scientists, Splaiul Independentei, no. 54, sector 5, 050094 Bucharest, Romania; [email protected] (S.R.); [email protected] (D.R.) 3 Mid Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield WF1 4DG, UK; [email protected] 4 York Hospital, Wigginton road Clifton, York YO31 8HE, UK; [email protected] 5 Leeds Teaching Hospitals NHS Trust, Great George St, Leeds LS1 3EX, UK; [email protected] 6 Laboratory of Neuropathology and Electron Microscopy, School of Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece 7 Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, no 16, 700115 Iasi, Romania; [email protected] 8 Discipline of Psychiatry, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, Dionisie Lupu Street, no 37, 020021 Bucharest, Romania; [email protected] * Correspondence: [email protected] (O.-D.I.); [email protected] (A.C.) Received: 17 September 2020; Accepted: 17 November 2020; Published: 19 November 2020 Abstract: Intra-lysosomal accumulation of the autofluorescent “residue” known as lipofuscin, which is found within postmitotic cells, remains controversial. Although it was considered a harmless hallmark of aging, its presence is detrimental as it continually accumulates.
    [Show full text]
  • NCL Description for Cocker Spaniels
    NCL Description for Cocker Spaniels Age of onset of clinical signs: 1.5 - 6 years Age of death or euthanasia: 1.5 - 6 years Abnormalities often observed by the owner: Mental changes: Aggression, irritability, dementia Changes in gait and posture: progressive difficulty walking; weakness and uncoordinated movement. Visual abnormalities: blindness may be present in some cases Seizures/convulsions: reported in some cases Other changes: Jaw champing, head tremors, emaciation Abnormalities observed upon clinical examinations: Clinical neurologic changes: Gait abnormalities, weakness, uncoordinated movement (hypermetric ataxia, proprioceptive deficits, exaggerated spinal reflexes) Clinical ophthalmic changes: ophthalmic changes have been reported Visual abnormalities: blindness has been reported Retinal changes: retinal atrophy has been reported Electroretinography (ERG): not described in reported cases Other clinical findings: none reported Histopathology Brain: Yellow-brown granules were present in neuronal cytoplasm of some neurons in the brain and spinal cord. Storage granules were most abundant in the spinal cord and cerebellum. Cells in the cerebral cortex, brain stem, and Purkinje cells were less affected. Affected neurons were swollen, and often had an eccentric nucleus due to displacement by accumulation of granules. These granules exhibited yellow-green autofluorescence and staining patterns consistent with ceroid and lipofuscin. Degenerative changes within the CNS were also described (neuronal necrosis, Wallerian degeneration, and axonal dystrophy). Eyes: mild irregular loss of photoreceptor cells; massive accumulation of fluorescent material in the retinal pigmented epithelium. Other organs and structures: Storage product also accumulated within the smooth muscle cells of the intestines, pancreas, urinary bladder, and walls of small arteries. Mode of inheritance: Autosomal recessive inheritance is suspected.
    [Show full text]
  • Amyloid Precursor Protein, Lipofuscin Accumulation and Expression of Autophagy Markers in Aged Bovine Brain D
    De Biase et al. BMC Veterinary Research (2017) 13:102 DOI 10.1186/s12917-017-1028-1 RESEARCH ARTICLE Open Access Amyloid precursor protein, lipofuscin accumulation and expression of autophagy markers in aged bovine brain D. De Biase1, A. Costagliola1*, T.B. Pagano1, G. Piegari1, S. Wojcik2, J. Dziewiątkowski2, E. Grieco3, G. Mattace Raso4, V. Russo1, S. Papparella1 and O. Paciello1 Abstract Background: Autophagy is a highly regulated process involving the bulk degradation of cytoplasmic macromolecules and organelles in mammalian cells via the lysosomal system. Dysregulation of autophagy is implicated in the pathogenesis of many neurodegenerative diseases and integrity of the autophagosomal - lysosomal network appears to be critical in the progression of aging. Our aim was to survey the expression of autophagy markers and Amyloid precursor protein (APP) in aged bovine brains. For our study, we collected samples from the brain of old (aged 11–20 years) and young (aged 1–5 years) Podolic dairy cows. Formalin-fixed and paraffin embedded sections were stained with routine and special staining techniques. Primary antibodies for APP and autophagy markers such as Beclin-1 and LC3 were used to perform immunofluorescence and Western blot analysis. Results: Histologically, the most consistent morphological finding was the age-related accumulation of intraneuronal lipofuscin. Furthermore, in aged bovine brains, immunofluorescence detected a strongly positive immunoreaction to APP and LC3. Beclin-1 immunoreaction was weak or absent. In young controls, the immunoreaction for Beclin-1 and LC3 was mild while the immunoreaction for APP was absent. Western blot analysis confirmed an increased APP expression and LC3-II/LC3-I ratio and a decreased expression of Beclin-1 in aged cows.
    [Show full text]
  • Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
    cells Review Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases Ping Song * , Junqing An and Ming-Hui Zou Center for Molecular and Translational Medicine, Georgia State University, 157 Decatur Street SE, Atlanta, GA 30303, USA; [email protected] (J.A.); [email protected] (M.-H.Z.) * Correspondence: [email protected]; Tel.: +1-404-413-6636 Received: 29 January 2020; Accepted: 5 March 2020; Published: 10 March 2020 Abstract: Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, and apoptotic resistance in multiple organs due to various stressors. Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing. Immune cells can remove senescent cells. Immunaging or impaired innate and adaptive immune responses by senescent cells result in persistent accumulation of various senescent cells. Although senolytics—drugs that selectively remove senescent cells by inducing their apoptosis—are recent hot topics and are making significant research progress, senescence immunotherapies using immune cell-mediated clearance of senescent cells are emerging and promising strategies to fight ageing and multiple chronic diseases. This short review provides an overview of the research progress to date concerning senescent cell-caused chronic diseases and tissue ageing, as well as the regulation of senescence by small-molecule drugs in clinical trials and different roles and regulation of immune cells in the elimination of senescent cells. Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan. Keywords: cellular senescence; senescence immunotherapy; ageing; chronic disease; ageing markers 1.
    [Show full text]
  • Gait Mechanics in Patients with Chronic Obstructive Pulmonary Disease Jenna M
    University of Nebraska at Omaha DigitalCommons@UNO Journal Articles Department of Biomechanics 2-2015 Gait mechanics in patients with chronic obstructive pulmonary disease Jenna M. Yentes University of Nebraska at Omaha, [email protected] Kendra K. Schmid University of Nebraska Medical Center Daniel Blanke University of Nebraska at Omaha, [email protected] Debra J. Romberger University of Nebraska Medical Center Stephen I. Rennard University of Nebraska Medical Center See next page for additional authors Follow this and additional works at: https://digitalcommons.unomaha.edu/biomechanicsarticles Part of the Biomechanics Commons Recommended Citation Yentes, Jenna M.; Schmid, Kendra K.; Blanke, Daniel; Romberger, Debra J.; Rennard, Stephen I.; and Stergiou, Nicholas, "Gait mechanics in patients with chronic obstructive pulmonary disease" (2015). Journal Articles. 128. https://digitalcommons.unomaha.edu/biomechanicsarticles/128 This Article is brought to you for free and open access by the Department of Biomechanics at DigitalCommons@UNO. It has been accepted for inclusion in Journal Articles by an authorized administrator of DigitalCommons@UNO. For more information, please contact [email protected]. Authors Jenna M. Yentes, Kendra K. Schmid, Daniel Blanke, Debra J. Romberger, Stephen I. Rennard, and Nicholas Stergiou This article is available at DigitalCommons@UNO: https://digitalcommons.unomaha.edu/biomechanicsarticles/128 Yentes et al. Respiratory Research (2015) 16:31 DOI 10.1186/s12931-015-0187-5 RESEARCH Open Access Gait mechanics in patients with chronic obstructive pulmonary disease Jennifer M Yentes1*, Kendra K Schmid2, Daniel Blanke1, Debra J Romberger3,4, Stephen I Rennard4 and Nicholas Stergiou1,2 Abstract Background: Chronic obstructive pulmonary disease (COPD) is characterized by the frequent association of disease outside the lung.
    [Show full text]
  • Complement Activation by Photooxidation Products of A2E, a Lipofuscin Constituent of the Retinal Pigment Epithelium
    Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium Jilin Zhou*, Young Pyo Jang*, So Ra Kim*, and Janet R. Sparrow*†‡ Departments of *Ophthalmology and †Pathology and Cell Biology, Columbia University, New York, NY 10032 Edited by Nicholas J. Turro, Columbia University, New York, NY, and approved September 19, 2006 (received for review May 23, 2006) Recent studies have implicated local inflammation and activation responsible for activating complement and local inflammatory of complement amongst the processes involved in the pathogen- events are not known, but infectious agents and sequela related esis of age-related macular degeneration (AMD). Several lines of to oxidative processes have been suggested (13, 15). investigation also indicate that bis-retinoid pigments, such as A2E, The complement cascade is an effector system that, upon that accumulate as lipofuscin in retinal pigment epithelial (RPE) activation, generates a number of bioactive products, some of cells, contribute to the disease process. In an investigation of a which including the complement cleavage products C3a and potential trigger for complement activation in AMD, we explored C5a, trigger inflammatory responses (16–18). Activation of the notion that the complex mixture of products resulting from complement can occur by three different pathways, two of photooxidation of A2E might include a range of fragments that these being the classical and alternative pathways. In the could be recognized by the complement system as ‘‘foreign’’ and classical pathway, activation is initiated by binding of protein that could serve to activate the complement system, leading to C1q, the recognition subunit of the C1 complex, to an acti- low-grade inflammation.
    [Show full text]
  • Materials, Methods & Technologies ISSN 1314-7269, Volume 10, 2016
    Materials, Methods & Technologies Journal of International Scientific Publications ISSN 1314-7269, Volume 10, 2016 www.scientific-publications.net A RAPID PLATFORM TO GENERATE LIPOFUSCIN AND SCREEN THERAPEUTIC DRUGS FOR EFFICACY IN LIPOFUSCIN REMOVAL Jason Gaspar, Jacques Mathieu, Pedro J. J. Alvarez Rice University Dept. of Civil and Environmental Engineering, Houston, Texas, 77005 Abstract Lipofuscin is a brown-yellow, autofluorescent polymeric material that accumulates in a ceroid manner within postmitotic cells during aging. Lipofuscin accumulation impairs proteosome and lysosome pathways critical to cell health and homeostasis. Therefore, the ability to quickly generate lipofuscin in vitro, and identify drugs that mitigate the accumulation or clear lipofuscin would be of great benefit to aging research. Here, we present a platform to quickly create lipofuscin-loaded (but otherwise healthy) cells and screen drugs for efficacy in lipofuscin removal. The combination of leupeptin, iron (III) chloride and hydrogen peroxide generates significant amounts of lipofuscin within cells while eliminating the need for a 40% hyperoxic chamber. Alternative methods which load fibroblasts with “artificial” lipofuscin obtained via UV-peroxidation of mitochondrial fragments are much more labor-intensive. 7KLVPHWKRGLVIDVWHU GD\V WKDQPRVWSURWRFROVWRJHQHUDWHOLSRIXVFLQDQGDVVHVV its removal, which typically require 2 to 4 weeks or longer to complete. Key words: lipofuscin, flow cytometry, Fenton chemistry, autofluorescence, fluorescent microscopy 1. INTRODUCTION Lipofuscin accumulation has an inverse relationship with lifespan and is a well-documented hallmark of aging. (Nakano et al., 1995; Terman and Brunk, 2004) Many age-related disease states including Alzheimer’s (Moreira et al., 2007), Parkinson’s (Meredith et al., 2002), and age-related macular degeneration (Sparrow et al., 2000) show increased lipofuscin accumulation.
    [Show full text]
  • Implication of Dietary Iron-Chelating Bioactive Compounds in Molecular Mechanisms of Oxidative Stress-Induced Cell Ageing
    antioxidants Review Implication of Dietary Iron-Chelating Bioactive Compounds in Molecular Mechanisms of Oxidative Stress-Induced Cell Ageing Alexandra Barbouti 1,* , Nefeli Lagopati 2, Dimitris Veroutis 2, Vlasios Goulas 3 , Konstantinos Evangelou 2, Panagiotis Kanavaros 1, Vassilis G. Gorgoulis 2,4,5,6 and Dimitrios Galaris 7 1 Department of Anatomy-Histology-Embryology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; [email protected] 2 Laboratory of Histology-Embryology, Molecular Carcinogenesis Group, Faculty of Medicine, School of Health Science, National and Kapodistrian University of Athens, 75, Mikras Asias Str., Goudi, 11527 Athens, Greece; [email protected] (N.L.); [email protected] (D.V.); [email protected] (K.E.); [email protected] (V.G.G.) 3 Department of Agricultural Sciences, Biotechnology and Food Science, Cyprus University of Technology, 3036 Lemesos, Cyprus; [email protected] 4 Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece 5 Faculty of Biology, Medicine and Health Manchester Cancer Research Centre, Manchester Academic Health Sciences Centre, University of Manchester, Manchester M13 9PL, UK 6 Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece 7 Laboratory of Biological Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; [email protected] Citation: Barbouti, A.; Lagopati, N.; * Correspondence: [email protected]; Tel.: +30-2651007613 Veroutis, D.; Goulas, V.; Evangelou, K.; Kanavaros, P.; Gorgoulis, V.G.; Abstract: One of the prevailing perceptions regarding the ageing of cells and organisms is the Galaris, D. Implication of Dietary intracellular gradual accumulation of oxidatively damaged macromolecules, leading to the decline of Iron-Chelating Bioactive Compounds cell and organ function (free radical theory of ageing).
    [Show full text]
  • Autofluorescence: Causes and Cures
    Autofluorescence: Causes and Cures Table of contents 1 Introduction.....................................................................................................................................2 2 Natural Fluorescence.....................................................................................................................3 2.1 Lipofuscins ............................................................................................................................................... 3 2.1.1 Protocols for reducing Lipofuscin fluorescence ........................................................................ 3 2.2 Elastin and Collagen ................................................................................................................................ 4 2.2.1 Protocol for reducing Elastin fluorescence ............................................................................... 4 3 Fixative-induced fluorescence......................................................................................................5 3.1 Protocols for reducing fixative-induced fluorescence.......................................................................... 5 3.1.1 Sodium Borohydride ................................................................................................................ 5 3.1.2 Trypan Blue treatment ............................................................................................................. 6 3.1.3 Avoiding Aldehyde fixatives ....................................................................................................
    [Show full text]
  • Lipofuscinosis of the Gastrointestinal Tract in Man
    J Clin Pathol: first published as 10.1136/jcp.20.6.806 on 1 November 1967. Downloaded from J. clin. Path. (1967), 20, 806 Lipofuscinosis of the gastrointestinal tract in man BERNARD FOX From the Department of Morbid Anatomy, Charing Cross Hospital Medical School, London SYNOPSIS Three illustrative cases of lipofuscinosis of the gastrointestinal tract are presented. The nature and significance of this condition are discussed. When the pigment is found in surgical biopsy material steatorrhoea, hypoalbuminaemia, and vitamin E deficiency should be excluded. It is probable that this type of lipofuscinosis is a manifestation of vitamin E deficiency in man. Brown pigmentation (lipofuscinosis) of the bowel This paper describes three cases of lipofuscin was first recorded in necropsy material from patients pigmentation of the gastrointestinal tract discovered dying from a variety of diseases (Blaschko, 1883; in surgical biopsy material, describes in detail the Scheimpflug, 1885). The pigmentation was described histological distribution and staining characteristics as being mainly in the small intestine and was of the pigment, discusses the significance of the thought to be a degenerative change. Pappenheimer finding, and emphasises its diagnostic value in the and Victor (1946) reported pigmentation in the malabsorption syndrome, hypoproteinaemia, and smooth muscle of the oesophagus, stomach, and vitamin E deficiency. small intestine in necropsy material from patients with the malabsorption syndrome. This observation CASE REPORTS copyright. has been confirmed in idiopathic steatorrhoea CASE 1 A 61-year-old man was admitted to hospital (Adlersberg and Schein, 1947; Ansanelli and Lane, in 1963 for investigation of indigestion and recent loss 1957; Gresham, Cruickshank, and Valentine, 1958; of 13 kg.
    [Show full text]
  • Formation of Lipofuscin-Like Autofluorescent Granules
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.23.432539; this version posted February 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. FORMATION OF LIPOFUSCIN-LIKE AUTOFLUORESCENT GRANULES IN THE RETINAL PIGMENT EPITHELIUM REQUIRES LYSOSOME DYSFUNCTION Cristina Escrevente1, Ana S. Falcão1, Michael J. Hall2, Mafalda Lopes-da- Silva1, Pedro Antas1, Miguel M. Mesquita1, Inês S. Ferreira1, M. Helena Cardoso1, Ana C. Fradinho1, Clare E. Futter2, Sandra Tenreiro1 and Miguel C. Seabra1,2 1 iNOVA4Health, CEDOC - Chronic Diseases Research Center, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal 2 UCL Institute of Ophthalmology, London, UK. Correspondence: Miguel C. Seabra, CEDOC - NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal Short Title: Lysosome Dysfunction and Autofluorescent Granules Keywords: retinal pigmented epithelium; photoreceptor outer segments; autofluorescent granules; lipofuscin; lysosome dysfunction Grant Support: 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.23.432539; this version posted February 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. This work was supported by Fundação para a Ciência e Tecnologia (FCT) – Portugal co-funded by FEDER under the PT2020 Partnership Agreement (to MCS, including project PTDC/MED-PAT/30385/2017, iNOVA4Health- UIDB/04462/2020, research infrastructure PPBI-POCI-01-0145-FEDER-022122, M-ERA.NET 2/0005/2016), Boehringer Ingelheim (to MCS), Fight for Sight UK (to MCS), Wellcome Trust grant number 212216/Z/18/Z/ (to CEF).
    [Show full text]